반응식
[CH3:1][C:2]([C:10]1[CH:15]=[CH:14][C:13]([C@H:16]2[CH2:21][C@@H:20]([OH:22])[CH2:19][CH2:18][NH:17]2)=[C:12]([OH:23])[CH:11]=1)([CH3:9])[CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH3:8].[C:24](Br)#[C:25][CH3:26].C(=O)([O-])[O-].[K+].[K+]>>[CH2:26]([N:17]1[CH2:18][CH2:19][C@H:20]([OH:22])[CH2:21][C@@H:16]1[C:13]1[CH:14]=[CH:15][C:10]([C:2]([CH3:1])([CH3:9])[CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH3:8])=[CH:11][C:12]=1[OH:23])[C:25]#[CH:24]참가 물질
4
실험 절차
Employing the procedure of Example 10 with 321 mg (1.01 mmole) of cis-2-[4-(1,1-dimethylheptyl)-2-hydroxyphenyl]-4-piperidinol, 82 microliter (1.06 mmole) or propynyl bromide and 292 mg (2.12 mmole) of potassium carbonate affords 205 mg (57%) of the title compound as an oil.
출처 및 근거
- ORD 기록
- ord-369fd318923a4ab2b381bdc985bb373d
- 출처 데이터셋
- uspto-grants-1985_07
- 특허 번호
- US04529732
연결된 노트
불러오는 중…